The NIH has awarded inaugural funding to three institutions to establish a new genome centre for the All of Us Research Program.
Rady Children’s Hospital has launched a new, California State-funded initiative called Project Baby Bear to cover rWGS for critically ill newborns across the state.
SOPHiA GENETICS has announced that they are opening a new headquarters in Boston, Massachusetts to accommodate growing US demand.
ASCO checkpoint inhibitor battle between Merck and Roche highlights the pitfalls in directly comparing clinical trial results in the era of precision medicine.
Precision medicine is showing significant signs of success across tumour types.
Researchers have discovered a new class of anti-cancer drugs that can stop specific cancer cells from proliferating—putting them to “sleep,” potentially permanently.
Despite representing over 40% of the global population, Asians are vastly underrepresented in genetic databases contributing around 1%. We take a look at how FDNA, and other key players are changing this.
Researchers at the Key Laboratory of Synthetic Biology in Shanghai have used CRISPR to create a new species of yeast that only has a single giant chromosome.
Scientists at Dana-Farber Cancer Institute have solved a mystery that has lingered ever since the dangers of the drug first became apparent: how did the drug produce such severe fetal harm?
Researchers from the University of Alabama have identified a method by which it is possible to reduce the signs of ageing, such as wrinkles and hair loss, in mice.
For the first time, an artificial mouse embryo has successfully passed a critical developmental milestone in the lab.
A new study provides the first evidence of how the human brain recovers the ability to function after losing parts of the visual system.
Scientists have uncovered a potential new role for long noncoding RNA in obesity and nonalcoholic fatty liver disease.
Researchers may have found a weakness in a protein that delivers the flu virus that could be a useful target to stop the virus from infecting cells.
The DNA sequencing market in China is expected to reach 18.3B Yuan by 2022, rising from 7.2B Yuan last year at a much greater rate than the overall global market.